Wendy A. Gattis

Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: Insights from the Flolan International Randomized Survival Trial (FIRST)

Christopher M. O’Connor, Wendy A. Gattis, Barry F. Uretsky et al. · American Heart Journal · 1999 · 515 citations

Heart Failure, Cardiovascular Disease, Patient Safety +10

Reduction in Heart Failure Events by the Addition of a Clinical Pharmacist to the Heart Failure Management Team

Wendy A. Gattis, Vic Hasselblad, David J. Whellan et al. · Archives of Internal Medicine · 1999 · 462 citations

Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure

Wendy A. Gattis, Christopher M. O’Connor, Dianne Gallup et al. · Journal of the American College of Cardiology · 2004 · 373 citations

Heart Failure, Cardiogenic Shock, Cardiovascular Disease +8

Organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF): rationale and design

Gregg C. Fonarow, William T. Abraham, Nancy M. Albert et al. · American Heart Journal · 2004 · 340 citations

Heart Failure, Patient Safety, Cardiac Care +6

Relationship of Serum Digoxin Concentration to Mortality and Morbidity in Women in the Digitalis Investigation Group Trial

Kirkwood F. Adams, J. Herbert Patterson, Wendy A. Gattis et al. · Journal of the American College of Cardiology · 2005 · 276 citations

Toxicology, Serum Digoxin Concentration, Health Studies +3